Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
4.390
+0.020 (0.46%)
At close: Jul 24, 2026, 4:00 PM EDT
4.420
+0.030 (0.68%)
After-hours: Jul 24, 2026, 7:34 PM EDT
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $5.47 million as of July 24, 2026. Its market cap has increased by 320.80% in one year.
Market Cap
5.47M
Enterprise Value
-4.63M
1-Year Change
320.80%
Ranking
Category
Stock Price
$4.39
ChartMarket Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $131.30M to $5.47M, a decrease of -95.83%. That is a compound annual growth rate of -27.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 5.50M | -37.50% |
| Dec 31, 2025 | 8.80M | 300.00% |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -73.77% |
| Dec 30, 2022 | 12.20M | -66.94% |
| Dec 31, 2021 | 36.90M | -75.47% |
| Dec 31, 2020 | 150.40M | 367.08% |
| Dec 31, 2019 | 32.20M | 2.88% |
| Dec 31, 2018 | 31.30M | -70.02% |
| Dec 29, 2017 | 104.40M | 161.00% |
| Dec 30, 2016 | 40.00M | -69.54% |
| Jul 20, 2016 | 131.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Purple Biotech | 6.10M |
| BioAtla | 5.88M |
| CollPlant Biotechnologies | 5.86M |
| Evogene | 5.78M |
| Cadrenal Therapeutics | 5.77M |
| Adial Pharmaceuticals | 5.77M |
| Curanex Pharmaceuticals | 5.76M |
| NuCana | 5.62M |